期刊文献+

住院患者慢性肾脏病患病情况的调查 被引量:5

Prevalence of chronic kidney disease in Chinese hospitalized adult patients:investigation of 13 383 cases
原文传递
导出
摘要 目的我国有关慢性肾脏病(CKD)流行情况的大样本临床调查资料报道较少,本研究拟在调查三级甲等医院住院患者 CKD 的患病情况。方法回顾性分析了2004年9月到2005年8月在南京市中大医院(三级甲等)住院的所有成人患者(≥18岁)的病历资料,共16 946份病历,剔除未检查肾功能的病历和同一患者重复住院的病历,最终有效入选病历为13 383份,男性6215例,女性7168例,观察患者的性别、年龄、高血压和糖尿病史、吸烟史、血压、肾功能、尿酸、白蛋白、血红蛋白、红细胞压积、血脂、尿蛋白等多项指标,参照 NKF-K/DOQI 指南的标准来定义 CKD,以简化的 MDRD公式求 eGFR。结果本研究中 CKD 患病率14.82%,其中 CKD1-5期患者所占比例分别为3.33%、2.49%、7.07%、1.08%和0.86%。大于65岁的老年患者占 CKD 的53.07%,其 CKD 患病率高于中青年患者(P<0.001)。9.01%的患者 eGFR 低于60 ml·min^(-1)·(1.73 m^2)^(-1),老年患者 eGFR 降低比例高于中青年患者(P<0.001)。尿蛋白阳性率8.87%,老年患者阳性率高于中青年患者(P<0.001)。高血压、糖尿病和原发性肾小球疾病是导致 CKD 的主要病因,分别占29.49%、11.64%、4.39%。有39.06%的 CKD 患者在住院期间未能做出 CKD 诊断,且都为 CKD1-3期患者。Logistic 回归提示高血压、糖尿病、年龄增长是 CKD 的重要危险因素。结论 CKD 是住院成人患者常见的一种慢性疾病,老年人是高危人群,高血压、糖尿病是最主要的病因,积极应用 K/DOQI 指南标准及时做出CKD 诊断,对早期预防和积极干预 CKD,降低终末期肾脏疾病的发生具有重要意义。 Objective To retrospectively investigate the prevalence and distribution of chronic kidney disease (CKD) in hospitalized Chinese adult patients. Methods The medical histories of 13383 adult patients hospitalized in Zhongda Hospital from September 2004 to August 2005, 6215 males and 7168 female, aged (51 + 19 ) (18 - 103 ), were reviewed. The blood pressure, serum creatinine, proteinuria were investigated. CKD was defined and classified according to the NKF/DOQI guideline. Glomerular filtration rate (GFR) was estimated by using the simplified modification of diet in renal disease study (MDRD) equation, eGFR = 186.3 × serum creatinine^-1.154 ×age^-0.203 ×(0. 742 for women) ml ·min^-1· ( 1.7 3 m^2 )^ -1. Results The prevalence rate of CKD was 14.82% in this group, and the prevalence rates of CKD of stage 1 to 5 were 3.33%, 2.49%, 7.07%, 1.08%, and 0.86% respectively. 53.07% of the CKD patients were elderly patients (age 〉 65 ) with a CKD prevalence rate of 29.47%, significantly higher than that of the middle-aged and young patients (9.49%, P 〈 0.01 ). The eGFR levels of 9.01% of the hospitalized patients were below 60 ml ·min^-1·( 1.73 m^2 ) ^-1. The prevalence rate of proteinuria was 8. 87%. 39. 06% of the patients at stages 1 - 3 failed to be diagnosed as with CKD during their hospitalization. The most common causes of CKD were hypertension (29.49%), diabetes (11.64% ), and primary glomerulonephritis (4.39%). Hypertension, diabetes and being elderly were main risk factors for CKD. Conclusion CKD is a very common disease among the hospitalized patients in China. With the increasing number of aging populations, elderly people will be the highest risk group for CKD. More strategies have to be made for its early detection and prevention.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第38期2672-2676,共5页 National Medical Journal of China
关键词 肾功能衰竭 慢性 流行病学 患病率 Kidney failure,chronic Epidemiology Prevalence
  • 相关文献

参考文献20

  • 1Coresh J,Astor BC,Greene T,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population. Am J Kidney Dis,2003,41:1-12.
  • 2Lameire N, Jager K, Van Biesen W, et al. Chronic kidney disease : a European perspective. Kidney Int Suppl,2005,68 :S30-S38.
  • 3Wang H,Zhang L, Lv J. Prevantion of the progression of chronic kidney disease : practice in China. Kidney hat Suppl, 2005,67 : S63 -S67.
  • 4Coresh J, Byrd-Hoh D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol,2005,16:150-155.
  • 5Xue JL,Ma JZ,Louis TA,et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol,2001,12:2753-2758.
  • 6Li ZY, Xu GB, Wang HY, et al. Prevalence of chronic kidney disease in a middle and old-aged population of Beijing. Clin Chim Acta, 2006,366:209 -215.
  • 7National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis,2002,39:S1-S266.
  • 8Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol,2003,14 :S131 -S138.
  • 9Mathew T. Addressing the epidemic of chronic kidney disease in Australia. Nephrology ,2004,9 : S109-S112.
  • 10United States Renal Data System. Annum data report: incidence and prevalence of ESRD ( 2003 ). Am J Kidney Dis, 2003,42 : S37-S173.

二级参考文献10

  • 1Levey AS, Greene T, Kusek JW, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol,2000,11: A828.
  • 2Levey AS, Bosch JP, Levis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med,1999,130:461-470.
  • 3Cockcroft DW, Gault MH.Prediction of creatinine clearance from serum creatinine.Nephron,1976,16:31-41.
  • 4Blaufox MD, Aurell M, Bubeck B,et al.Report of the Radionuclides in Nephrourology Committee on renal clearance.J Nucl Med,1996,37:1883-1890.
  • 5Lewis J, Agodoa L, Cheek D, et al.Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.Am J Kidney Dis,2001,38:744-753.
  • 6Vervoort G, Willems HL, Wetzels JF.Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation.Nephrol Dial Transplant,2002,17:1909-1913.
  • 7Coresh J, Toto RD, Kirk KA, et al.Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study.Am J Kidney Dis, 1998,32:32-42.
  • 8Fleming JS, Wilkinson J, Oliver RM, et al.Comparison of radionuclide estimation of glomerular filtration rate using technetium 99m diethylenetriaminepentaacetic acid and chromium 51 ethylenediaminetetraacetic acid.Eur J Nucl Med,1991,18:391-395.
  • 9Jiang ZM, Yang NF, Chou C,et al. Body composition in Chinese subjects: comparison with data from North America.World J Surg,1991,15:95-102.
  • 10王海燕 王梅主译.慢性肾脏病及透析的临床实践指南[M].北京:人民卫生出版社,2003.46-471.

共引文献516

同被引文献39

  • 1马骁,黎莉,管益君,张薇.虫草复方制剂对动脉粥样硬化的作用机制[J].山东大学学报(医学版),2005,43(1):54-56. 被引量:3
  • 2α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志,2005,21(7):421-424. 被引量:134
  • 3陈晓农,陈楠.慢性肾脏病的心血管危险因素及其防治[J].中国实用内科杂志:临床前沿版,2006,26(4):617-619. 被引量:7
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 5Ronco C,Bowry S,Tetta C.Dialysis patients and cardiovascularproblems:Can technology help solve the complex equation[J].Blood Purif,2006,24(1):39-45.
  • 6Celermajer D S,Sorensen K E,Gooch V M,et al.Non-invasivedetection of endothelial dysfunction in children and adults at riskof atherosclerosis[J].Lancet,199,2340(8828):1111-1115.
  • 7Snyder J J,Foley R N,Collins A J.Prevalence of CKD in the U-nited States:a sensitivity analysis using the National Health andNutrition Examination Survey(NHANES)1999-2004[J].Am JKidney Dis,2009,53(2):218-228.
  • 8Sidhu M S,Dellsperger K C.Cardiovascular problems in dialysispatients:impact on survival[J].Adv Perit Dial,2010,26:47-52.
  • 9Lind L,Berglund L,Larsson A,et al.Endothelial function in re-sistance and conduit arteries and 5-year risk of cardiovascular dis-ease[J].Circulation,2011,123(14):1545-1551.
  • 10朱运锋,谌贻璞,芮宏亮,董鸿瑞,胡昭.虫草菌粉对慢性马兜铃酸肾病大鼠模型肾间质纤维化的保护作用[J].中华医学杂志,2007,87(38):2667-2671. 被引量:29

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部